Study of JTX-8064, as Monotherapy and in Combination With a PD-1 Inhibitor, in Adult Subjects With Advanced Refractory Solid Tumors
Clinical trial NCT04669899 · COMPLETED
Trial details
- NCT number
- NCT04669899
- Sponsor
- Jounce Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-12
- Primary completion
- 2023-11-28
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.